Untitled Document
Hathaway Corporation - Your next step

Call Us: 817-812-2104
"The future is now"
Building tomorrow's technology through today's innovations.
 
 


 Home:  
 
About Hathaway Companies Investors Contact Us

Company news:

Corporate Home:


Stock quote
: HWYI

Opticon Systems Home:
Diabetic Detection Inc:

Hathaway (HWYI) Enters into LOI with Korean
Medical device Manufacturer, U & I Bio-Tech, Inc.
More >>

Hathaway (HWYI) Subsidiary OptiCon Systems, Inc. Receives Trading
Symbol from FINRA
More >>

Hathaway (HWYI) to Begin Spin-Off of Subsidiary Diabetes Detection Inc.
More >>


Monday July 30, 2007

Hathaway (HWYI) Wholly Owned Subsidiary, Diabetes Detection, Inc. (DDI) Signs Development Deal With Daviscomms (S) Pte Ltd.

Global Manufacturer to Develop Pager Technology With DDI to Detect and Monitor Diabetic Neuropathy

PALO ALTO, CA--(MARKET WIRE)--Jul 30, 2007 -- Hathaway Corporation (Other OTC:HWYI.PK - News), a company that focuses on acquiring, developing, and managing disruptive technologies in the telecommunications, medical devices, and software fields, announced that their wholly owned subsidiary DDI has signed a product development and manufacturing deal with Daviscomms (S) Pte Ltd., a global player in design and manufacturing of wireless communications and electronic products.

Under the terms of the deal, Daviscomms will integrate the patent pending DDI vibration technology into their pager units for the accurate detection and monitoring of diabetic neuropathy. A prototype of the device is anticipated as early as August 2007. DDI has already developed a prototype based on RIM's BlackBerry® device.

"We are excited to have an innovative global player in Daviscomms working closely with us in developing a pager unit that applies the DDI vibration technology. The device will be used by healthcare professionals worldwide to accurately detect and monitor diabetic neuropathy which can significantly increase a patient's health outlook for years to come," stated Mr. Reed Majors, President of DDI.

"The DDI technology, coupled with our design and manufacturing capabilities, will deliver innovative telemedicine products that can assist healthcare professionals worldwide in the fight against diabetes. We're proud to be associated with DDI and excited that this pioneering technology will ultimately impact millions of lives. We will readily assist DDI to penetrate global markets through our distribution partners worldwide," stated Mr. KK Liew, Managing Director of Daviscomms (S) Pte Ltd.

About DAVISCOMMS (S) PTE LTD

Daviscomms is in the business of providing Contract Design and Manufacturing services for a wide range of high quality consumer and industrial wireless electronics products such as pagers and paging systems, telemetry modules, and mobile handheld devices. With customers all over the world, Daviscomms is at the forefront of the industry due to its commitment to leading-edge technology, cost-effective manufacturing and the highest degree of customer service. http://www.daviscomms.com.sg/index.htm

About Hathaway

Hathaway Global Inc. focuses on acquiring disruptive technologies in the telecommunications, medical devices, and software fields that can change or alter the way companies grow and service their businesses. Hathaway provides financial and infrastructural support to create revenue growth companies, positioning them to leverage the opportunities such technologies are typically capable of. Hathaway then offers the company on the public market or facilitates a buyout. To request further information about Hathaway, please email us at investors@hathawayglobal.com

Safe Harbor

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.


Contact:
FutureTechIR for Hathaway Corporation
Investor Relations
(817) 812-2105 or
(727) 417-9338

Back >>

Untitled Document
Home | About |Companies |Investors | Contact Us
© 2008 - Hathaway Global, inc. , all rights reserved